| Patent application number | Description | Published |
|---|
| 20080238847 | Image display unit - An active matrix type display panel is a hold type display panel which has a plurality of pixels arranged in a matrix form, and holds and displays an electrical signal pixel by pixel for a predetermined time. A frame rate conversion circuit converts a video signal having a first vertical frequency (60 Hz) into a video signal having a second vertical frequency (120 Hz) which is m/n-fold (wherein m is an integer of 2 or more, n is an integer of 1 or more, and conditions of m>n are satisfied) of the first vertical frequency. A time base emphasizing circuit subjects an output from the frame rate conversion circuit to time base emphasis. A drive circuit displays the video signal having the second vertical frequency in a display panel. | 10-02-2008 |
| 20100238356 | Video signal processing method and apparatus - Low frequency components are extracted from a video signal for pixels in a specific area of an image carried by the signal. The low frequency components are allocated, based on luminance components of the signal, to gradations ranging from maximum to minimum levels exhibited by the luminance components, luminance histogram data being produced indicating the frequency of gradations for the pixels. The gradations are allocated to the pixels based on the luminance components to produce high-frequency component histogram data indicating the frequency of gradations for specific pixels each carrying a high frequency component. The luminance histogram data is corrected in accordance with the frequency of gradations in the high-frequency component histogram data to produce corrected luminance histogram data. A gradation correction curve is produced for correcting the gradations exhibited by the signal using the corrected data. The luminance components are corrected based on the correction curve. | 09-23-2010 |
| 20130076745 | DEPTH ESTIMATION DATA GENERATING APPARATUS, DEPTH ESTIMATION DATA GENERATING METHOD, AND DEPTH ESTIMATION DATA GENERATING PROGRAM, AND PSEUDO THREE-DIMENSIONAL IMAGE GENERATING APPARATUS, PSEUDO THREE-DIMENSIONAL IMAGE GENERATING METHOD, AND PSEUDO THREE-DIMENSIONAL IMAGE GENERATING PROGRAM - An RB rate calculator calculates an RB rate based on an R signal and a B signal. A starting point changing unit changes a starting point based on the RB rate. An offset calculating unit calculates an offset value to adjust for selection of a basic depth model type based on a bottom high frequency component evaluation value. An adding unit adds a signal from the starting point changing unit and an offset. Another adding unit adds an offset-added signal from the adding unit and a basic depth model-composed image signal supplied from a composing unit, and generates depth estimation data wherein a degree of superimposition of object information is changed according to a composition of a composed image of basic depth models selected to be composed. | 03-28-2013 |
| Patent application number | Description | Published |
|---|
| 20090030059 | PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE - Provided is a pharmaceutical composition for external use, including: (i) luliconazole represented by the following structural formula (1) and/or a salt thereof; and (ii) α-hydroxycarboxylic acid and/or a salt thereof. | 01-29-2009 |
| 20100076042 | PHARMACEUTICAL COMPOSITION - To provide a pharmaceutical composition which can enhance the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole without impairing the effect of the compound. | 03-25-2010 |
| 20120129905 | PHARMACEUTICAL COMPOSITION - To provide a pharmaceutical composition which can enhance the storage stability of 1-( | 05-24-2012 |
| 20120130148 | PHARMACEUTICAL COMPOSITION - To provide a pharmaceutical composition which can enhance the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole without impairing the effect of the compound. | 05-24-2012 |
| 20120136160 | PHARMACEUTICAL COMPOSITION - To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability. | 05-31-2012 |
| 20120149745 | ANTIMYCOTIC PHARMACEUTICAL COMPOSITION - A pharmaceutical composition which comprises 1) a compound represented by the following general formula (1) and/or a salt thereof; and 2) a ketone such as methyl ethyl ketone. Preferably, the compound represented by the following general formula (1) is luliconazole, where R | 06-14-2012 |
| 20130090365 | ANTIMYCOTIC PHARMACEUTICAL COMPOSITION - An object is to provide a medicament preparation which is excellent in the solubilization stability in relation to a compound represented by the general formula (1) during the storage in a low temperature region and a high temperature region. The present invention resides in a pharmaceutical composition comprising 1) the compound represented by the general formula (1) and/or a salt thereof and 2) a polyhydric alcohol derivative. General formula (1) (In the formula, R | 04-11-2013 |
| Patent application number | Description | Published |
|---|
| 20110200810 | LIGHT-SHIELDING FILM FOR OPTICAL ELEMENT AND OPTICAL ELEMENT HAVING LIGHT-SHIELDING FILM - A light-shielding film for optical element includes at least a resin and a colorant. The light-shielding film for optical element has an average extinction coefficient of 0.03 or more and 0.15 or less as an average of extinction coefficients of the whole light-shielding film for light having wavelengths ranging from 400 to 700 nm. | 08-18-2011 |
| 20110244219 | Antireflection Film for Optical Element, Antireflection Paint, and Optical Element - Provided is an antireflection paint for an optical element, including black primary particles and secondary particles, in which: the black primary particles each have at least a refractive index for a d line (nd) of 2.0 or more; a ratio between a maximum absorptivity of each of the black primary particles for light having a wavelength of 400 nm or more and 700 nm or less and a minimum absorptivity of each of the particles for the light is larger than 0.7; and the black primary particles have a smaller average particle diameter than an average particle diameter of the secondary particles. Such constitution can prevent surface reflection and internal reflection, absorb light in a visible region well, and alleviate an influence on an environment. | 10-06-2011 |
| 20120316265 | ANTIREFLECTION COATING FILM AND ANTIREFLECTION COATING MATERIAL FOR OPTICAL ELEMENT AND OPTICAL ELEMENT - An antireflection coating film for an optical element is provided on a surface of a substrate of an optical material and includes first particles having a refractive index (nd) of at least 2.2 or more for the d-line and an average particle size of 10 to 70 nm, second particles of at least one of silica and sericite and having an average particle size of 1 to 11 μm, a colorant of an organic substance and soluble in an organic solvent, and a resin, in which the first particle content is in the range of 10% to 35% by weight, and second particle content is in the range of 1% to 11% by weight. The antireflection coating film has a high effect of preventing surface reflection, a high effect of preventing inner-surface reflection, satisfactory absorption of visible light, and low levels of reflection and scattering in the film. | 12-13-2012 |
| 20140323612 | ANTIREFLECTION COATING FILM AND ANTIREFLECTION COATING MATERIAL FOR OPTICAL ELEMENT AND OPTICAL ELEMENT - An antireflection coating film for an optical element is provided on a surface of a substrate of an optical material and includes first particles having a refractive index (nd) of at least 2.2 or more for the d-line and an average particle size of 10 to 70 nm, second particles of at least one of silica and sericite and having an average particle size of 1 to 11 μm, a colorant of an organic substance and soluble in an organic solvent, and a resin, in which the first particle content is in the range of 10% to 35% by weight, and second particle content is in the range of 1% to 11% by weight. The antireflection coating film has a high effect of preventing surface reflection, a high effect of preventing inner-surface reflection, satisfactory absorption of visible light, and low levels of reflection and scattering in the film. | 10-30-2014 |
| 20150125689 | LIGHT-SHIELDING FILM FOR OPTICAL ELEMENT AND OPTICAL ELEMENT HAVING LIGHT-SHIELDING FILM - A light-shielding film for optical element includes at least a resin and a colorant. The light-shielding film for optical element has an average extinction coefficient of 0.03 or more and 0.15 or less as an average of extinction coefficients of the whole light-shielding film for light having wavelengths ranging from 400 to 700 nm. | 05-07-2015 |
| 20160024335 | LIGHT-SHIELDING PAINT, LIGHT-SHIELDING PAINT SET, LIGHT-SHIELDING FILM, OPTICAL ELEMENT, AND METHOD FOR PRODUCING OPTICAL ELEMENT - An optical element has a lanthanum-containing glass substrate and a light-shielding film on part of the surface of the glass substrate. The light-shielding film is made from a light-shielding paint that contains at least an epoxy resin, fine particles of titania, a dye, an organic solvent, and an amine-based curing agent. The organic solvent in the light-shielding paint has a vapor pressure of 160 Pa or more and 960 Pa or less at a temperature of 20° C. The viscosity of the light-shielding paint is 10.0 mPa·s or more and 100 mPa·s or less. | 01-28-2016 |
| 20160040031 | LIGHT-SHIELDING PAINT, LIGHT-SHIELDING PAINT SET, LIGHT-SHIELDING FILM, OPTICAL ELEMENT, METHOD FOR PRODUCING LIGHT-SHIELDING FILM, AND METHOD FOR PRODUCING OPTICAL ELEMENT - A light-shielding paint includes an epoxy group-containing compound, an inorganic fine particle, a coloring agent, and an amine curing agent. The ratio (A′/A) of the mass (A′) of the amine curing agent to the active hydrogen equivalent (A) of the amine curing agent and the ratio (E′/E) of the mass (E′) of the epoxy group-containing compound to the epoxy equivalent (E) of the epoxy group-containing compound satisfy 0.1≦[(A′/A)/(E′/E)]≦0.45. | 02-11-2016 |
| Patent application number | Description | Published |
|---|
| 20110014245 | THERAPEUTIC METHOD OF ADMINISTERING PHARMACEUTICAL TITANIUM DIOXIDE COMPOSITE AND LIGHT IRRADIATION - A titanium dioxide composite is provided that can be stably dispersed in an aqueous solvent and easily administered into a living body, such as human, and allows elimination of the drug efficacy of a pharmaceutical compound supported thereon by light irradiation and a dispersion thereof. A composite is used in which a pharmaceutical compound is bound to titanium dioxide having photocatalytic activity through a hydrophilic polymer. The composite is stable in an aqueous solvent and easily administered into a living body, and adverse drug reactions of the pharmaceutical compound can be reduced by administering the composite into the body and irradiating the composite with a light to photoexcite the titanium dioxide to decompose the pharmaceutical compound in a region where the drug efficacy of the pharmaceutical composition is not required. | 01-20-2011 |
| 20120081367 | SURGICAL SIMULATION MODEL GENERATING METHOD, SURGICAL SIMULATION METHOD, AND SURGICAL SIMULATOR - A surgical simulation model generating method includes: a first process in which a computing unit acquires geometrical information of an organ from a medical image stored in a storage unit, including an image of the organ, and generates volume data for the organ; a second process in which, after the first process, the computing unit forms nodal points by meshing the organ represented by the generated volume data; a third process in which the computing unit generates a simulated membrane that covers the organ represented by the volume data meshed in the second process; and a fourth process in which the computing unit generates a simulated organ by drawing an imaginary line so as to extend from each nodal point formed on a surface of the organ represented by the volume data meshed in the second process in a direction that intersects the simulated membrane and thereby forming a membrane nodal point at a point where the imaginary line intersects the simulated membrane generated in the third process, and by arranging on each imaginary line an imaginary inter-membrane spring that connects between the nodal point formed on the surface of the organ and the membrane nodal point, while also arranging an in-plane spring that connects between adjacent membrane nodal points on the simulated membrane. | 04-05-2012 |
| 20160063729 | SURGICAL SIMULATION MODEL GENERATING METHOD, SURGICAL SIMULATION METHOD, AND SURGICAL SIMULATOR - A surgical simulation model generating method which includes a first process in which a computing unit acquires geometrical information of an organ from a medical image stored in a storage unit, including an image of the organ, and generates volume data for the organ; a second process in which, after the first process, the computing unit forms nodal points by meshing the organ represented by the generated volume data; a third process in which the computing unit generates a simulated membrane that covers the organ represented by the volume data meshed in the second process; and a fourth process in which the computing unit generates a simulated organ by drawing an imaginary line so as to extend from each nodal point formed on a surface of the organ represented by the volume data meshed in the second process in a direction that intersects the simulated membrane. | 03-03-2016 |
